In 2018, the autotransfusion devices and consumables market was valued at $XX million and was expected to reach a value of $XX million by 2027, while growing at a CAGR of 6.14% between 2019 and 2027. The rising adoption of autotransfusion system over other blood transfusion techniques like allogenic blood transfusion is providing tremendous growth opportunities for the autotransfusion devices and consumables market in the region.
Countries like Germany, Spain, France, United Kingdom, and Italy are considered in the Europe autotransfusion devices and consumables market. The report also analyzed the Rest of Europe regional segment that is formed with a conglomeration of remaining European countries. The autotransfusion devices and consumables market in France is largely influenced by the increasing aging population, together with the prevalence of cardiovascular disorders. The advanced and well-established healthcare system in France adopts several modern technologies and devices, including autotransfusion devices catering to the needs of the population. As a result of this, the autotransfusion devices and consumables market is witnessing upsurge trend in the region.
LivaNova PLC, Getinge AB, Fresenius Medical Care, Kaneka Corporation, and Haemonetics Corporation, among others, are some of the eminent players of the autotransfusion devices and consumables market. The market is consolidated mainly by giant players. The high capital investments and strict licensing requirements pose as entry-level barriers for new entrants in the market.